Drug Compounding Scare Alarms Consumers
The barrage of stories about the compounding pharmacy scandal and the meningitis outbreak, which has claimed 19 lives, has begun to take a toll on public confidence in the safety of prescription medicines and injections, in general. Preliminary results of a new survey finds that people who read about the scandal are now more likely […]
Read More »Category : News
Threats Made Against Ex-Hedge Fund Manager Who Questions Provenge Efficacy
Source Earlier this year, a former hedge fund manager named Marie Huber co-authored a medical study that questioned the benefit of the Provenge prostate cancer vaccine, prompting yet another debate over the controversial medicine and, in the process, she received threatening remarks on investor message boards. Now, she is figuring in yet another flap. Documents […]
Read More »Category : News
Pfizer Wants CEO Far From Chantix Trial
Source In the latest instance in which a drugmaker is trying to keep its ceo from being questioned in front of a jury, Pfizer is appealing an order by a federal judge who recently granted a request that Ian Read and two other execs at the drugmaker take the witness stand in a lawsuit over […]
Read More »Category : News
Ex-Synthes Executives Excluded From Federal Healthcare Programs
Source In the latest example in which the federal government is trying to get tough with drug and device makers, former executives at Synthes, which is now owned by Johnson & Johnson, have been excluded from participating in federal healthcare programs, according to details on the web site of the US Department of Health […]
Read More »Category : News
GSK Opens Up Patient Clinical Trial Data for Review
Source In what may usher in a new era of transparency in the pharmaceutical industry, GlaxoSmithKline will make available patient-level data from its clinical trials to independent researchers, which means other scientists will have an opportunity to study the material and develop their own findings about safety and effectiveness. This also includes data for […]
Read More »Category : News
Novartis Employee Wins Age Discrimination Suit
Source After spending 11 years at a Novartis unit in Puerto Rico that makes the Ex-Lax laxative and other over-the-counter products, Hernán Acevedo-Parrilla was fired. And earlier this week, a federal appeals court overturned a lower court ruling and decided that sufficient evidence exists to suggest to a jury that he lost his job due […]
Read More »Category : News
Mounting Problems With Discontinuing Cymbalta
source There has always been concern about discontinuing antidepressants and withdrawal symptoms. But a new analysis finds that anywhere from 44 percent to 50 percent of Cymbalta patients experienced withdrawal symptoms after clinical trials, and more than half were resolved within two weeks. Moreover, there was a “serious breakdown†at both the FDA and Eli […]
Read More »Category : News
Fungal meningitis exposure may reach 13,000
The number of people infected with a rare type of meningitis tied to contaminated steroid injections has climbed to 105, federal health officials said Monday. Eight people have died. The drugs were given starting May 21, much earlier than previously suspected, officials with the Centers for Disease Control and Prevention said. Infections and deaths have […]
Read More »Category : News
KV Pharma Drug Compounding Uproar
source After getting beaten up for creating sticker shock over the price of its Makena treatment for premature births, KV Pharmaceutical is now relishing the controversy surrounding the New England Compounding Center, which has been linked to the outbreak of 105 cases of fungal meningitis and 13,000 people may have been exposed (see this). Why? […]
Read More »Category : News
Merck Shifts Global Headquarters
source In the latest big shift at Merck, the drugmaker is moving its global headquarters from one location in New Jersey to another. After being located in Whitehouse Station for 20 years in a complex that some derisively likened to CIA headquarters in Langley, Virginia, Merck is moving its key offices about 26 miles east […]
Read More »Category : News
